News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
More than 500 people have lost their jobs in the latest round of layoffs in Southern California, from FedEx and others. The latest government filings show that Staples and LAZ Parking were also among the companies cutting positions. FedEx layoffs continue to hit California …
Sharemaestro market context Price below Trend Line 52 weeks +67.9% · Next-week setup positive 57.0%Assenagon Asset Management S.A. significantly reduced its stake in IDEX Corporation, selling 81.9% of its holdings but still retaining shares valued at $5.51 million. Despite this reduction, institutional investors collectively own 97.96% of IDEX, and analysts maintain a "Moderate Buy" consensus rating with an …
Nike and FedEx have received billions in tariff refunds following a Supreme Court ruling, but their handling of these funds differs significantly. Nike will retain its nearly $1 billion refund as a boost to earnings, as the payments are not traceable to individual customers. …
Celldex Therapeutics (CLDX) recently reported wider losses and lower revenue for Q2 and H1 2026, yet its stock has seen significant recent gains. While the company trades at a 4.9x Price-to-Book multiple, suggesting it's overvalued compared to peers, a Discounted Cash Flow (DCF) model …
IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …
Sharemaestro market context Price above Trend Line 52 weeks -13.7% · Next-week setup negative 32.7%Standex International (SXI) has granted 2,285 Restricted Stock Units (RSUs) to Richard Colby Slaughter, CLO, VP, and Secretary, on August 10, 2026. These RSUs, tied to common stock, will vest in three equal installments on August 10, 2027, 2028, and 2029. Following this award, …
Richard Colby Slaughter, CLO, Vice President, and Secretary of Standex International Corp. (SXI), has filed an initial statement of beneficial ownership (Form 3). This filing establishes Slaughter as a reporting person but does not indicate any current equity holdings or transactions in company securities. …
DexCom Inc. (DXCM) saw its stock rise by 1.42% to $90.80 on Wednesday, marking its fifth consecutive day of gains. This performance outpaced the broader market, as the S&P 500 Index increased by 0.26% and the Dow Jones Industrial Average fell by 0.04% on …
DexCom director Bridgette P. Heller sold 1,012 shares of common stock at $88.29 per share on August 12, 2026, as part of a pre-established Rule 10b5-1 trading plan adopted in August 2025. Following the sale, Ms. Heller directly holds 29,570 shares, which includes 5,575 …
FedEx has introduced a Boeing 777 Freighter with a retro livery, N884FD named "Rosie," which is inspired by the Dassault Falcon 20s that launched the company in 1973. This unveiling coincides with the renaming of Memphis International Airport to Frederick W. Smith International Airport, …
DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …
Sharemaestro market context Trend signal active 52 weeks -3.4% · Next-week setup negative 24.8%DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …
Sharemaestro market context Trend signal active 52 weeks -3.4% · Next-week setup negative 24.8%DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth improves. The guidance increase is encouraging, but foreign exchange, …
Sharemaestro market context Trend signal active 52 weeks -3.4% · Next-week setup negative 24.8%DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …
Sharemaestro market context Trend signal active 52 weeks -3.4% · Next-week setup negative 24.8%This article details an SEC Form 144 filing by IDEX Corp /DE/ (IEX) on August 12, 2026. The filing indicates a proposed sale of 385 common shares with an aggregate market value of $91831.96, acquired through a stock option release on the same date. …
FedEx is set to lay off 116 employees following the closure of its facilities in Palm Springs and Victorville. The affected workers have already been notified of these impending layoffs. The news was reported by Sam Morgen of the Palm Springs Desert Sun.
Handelsbanken Fonder AB increased its stake in FedEx Corporation by 9.3% in the second quarter, acquiring an additional 9,783 shares and bringing its total holdings to 115,179 shares valued at $36.07 million. Other institutional investors also adjusted their positions, while a FedEx director sold …
Wasatch Advisors LP significantly reduced its stake in Standex International Corporation by 35.8% in Q2 2026, selling 470,971 shares but still holding 6.99% of the company's stock. Despite this reduction, other institutional investors increased their positions, and 90.35% of the stock is owned by …
Sei Investments Co. recently acquired a new stake of 38,152 shares in Celldex Therapeutics, Inc., valued at approximately $1.21 million. This comes as several other hedge funds have also adjusted their positions in the biopharmaceutical company. Celldex Therapeutics reported better-than-expected quarterly earnings and has …
This article provides recent news updates and stock performance for FedEx Corp (FDX), along with related logistics and freight companies. It highlights specific daily stock movements for FDX and its competitors like Union Pacific, Saia, XPO, CH Robinson, and UPS on various dates. The …
Mizuho has upgraded IDEX Corp (NYSE:IEX) to Outperform from Neutral and raised its price target to $280, citing the company's successful portfolio repositioning towards higher-growth, less-cyclical markets. This shift is leading to stronger organic growth and improved revenue visibility, with orders accelerating significantly in …
Assenagon Asset Management S.A. significantly reduced its stake in FedEx Corporation (NYSE:FDX) during the second quarter, selling 128,740 shares and retaining 19,189 shares valued at $6.0 million. FedEx recently reported quarterly revenues of $23.26 billion and earnings of $5.88 per share, also declaring a …
The average 12-month price target for Codexis, Inc. (CDXS) stock has been slightly cut from $6.58 to $6.5 by 6 analysts, with forecasts ranging from $2 to $11. This updated target implies a significant potential upside of approximately 339% based on the August 11 …
FedEx closed at $318.6 after a 3.6% weekly gain, sitting high in its 52-week range and above its weekly Trend Line, but the latest move came on only 0.8 times average volume as activity pressure cooled.
Barclays has updated its price target for IDEXX Laboratories (IDXX), lowering it to $710 from the previous $800. Despite this adjustment, the firm has decided to maintain its Overweight rating on the stock. This indicates a continued positive outlook on the company's performance, even …
IDEXX Laboratories Inc. has launched the Catalyst proBNP Test, an in-clinic diagnostic tool for heart disease in cats and dogs. This test measures the NT-proBNP biomarker, providing rapid quantitative results to veterinarians for screening, diagnosis, and monitoring of cardiac conditions. The test will be …
Codexis, Inc. reported a return to growth in its pharma biocatalysis business, driven by new product approvals and a significant label expansion. The company is strategically focusing on industrializing its ECOsynthesis platform to address projected siRNA demand, backed by recent equity financing and improved …
Search by ticker symbol or company name and select a result to open its chart.